This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Patrick Hanley
Immunotherapy GMP & Research Assistant Professor & Director at Children's National Health System, USA


Dr. Hanley is an assistant professor and director of the Cellular Therapy Laboratory at Children’s National. He oversees process development, translation, and manufacturing of cellular therapy products as well as immune monitoring of patients enrolled on clinical trials. An immunologist by training, over the past thirteen years he has helped to translate more than 20 cellular therapy protocols – ranging from mesenchymal stromal cells to cord blood virus-specific T cells and tumor-associated antigen specific T cells – into the clinic. He currently serves on the FACT board of directors and co-chairs ISCT’s Immuno-Gene Therapy committee and is a co-founder of Mana Therapeutics.